XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 25, 2021
Dec. 26, 2020
Cash flows relating to operating activities      
Net income $ 492,608,000 $ 398,837,000 $ 365,306,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 303,870,000 265,540,000 234,924,000
Stock-based compensation 73,617,000 71,474,000 56,341,000
Loss on debt extinguishment and amortization of other financing costs 4,118,000 29,964,000 3,661,000
Deferred income taxes (35,884,000) (24,006,000) (133,000)
Loss (gain) on venture capital and strategic equity investments, net 26,775,000 30,420,000 (100,861,000)
Provision for credit losses 6,706,000 1,657,000 6,376,000
Gain on divestitures, net (123,405,000) (25,026,000) 0
Changes in fair value of contingent consideration arrangements (3,753,000) (34,303,000) (468,000)
Other, net 27,542,000 3,300,000 7,704,000
Changes in assets and liabilities:      
Trade receivables and contract assets, net (150,570,000) (26,633,000) (85,627,000)
Inventories (78,523,000) (25,159,000) (18,379,000)
Accounts payable (2,652,000) 44,901,000 748,000
Accrued compensation (42,164,000) 44,304,000 40,481,000
Deferred revenue 57,658,000 (13,402,000) 28,647,000
Customer contract deposits 30,457,000 16,925,000 8,955,000
Other assets and liabilities, net 33,240,000 2,006,000 (1,100,000)
Net cash provided by operating activities 619,640,000 760,799,000 546,575,000
Cash flows relating to investing activities      
Acquisition of businesses and assets, net of cash acquired (283,392,000) (1,293,095,000) (418,628,000)
Capital expenditures (324,733,000) (228,772,000) (166,560,000)
Purchases of investments and contributions to venture capital investments (158,274,000) (45,555,000) (26,692,000)
Proceeds from sale of investments 4,549,000 6,532,000 11,401,000
Proceeds from divestitures, net 163,275,000 122,694,000 0
Other, net (9,347,000) 264,000 (1,065,000)
Net cash used in investing activities (607,922,000) (1,437,932,000) (601,544,000)
Cash flows relating to financing activities      
Proceeds from long-term debt and revolving credit facility 2,952,430,000 6,951,113,000 2,230,988,000
Proceeds from exercises of stock options 25,110,000 45,652,000 46,586,000
Payments on long-term debt, revolving credit facility, and finance lease obligations (2,932,636,000) (6,242,877,000) (2,200,400,000)
Purchase of treasury stock (38,651,000) (40,707,000) (23,979,000)
Payment of debt extinguishment and financing costs 0 (38,255,000) 0
Payments of contingent consideration (10,356,000) (2,328,000) 0
Purchases of additional equity interests, net (30,533,000) 0 0
Other, net (7,761,000) 0 (5,947,000)
Net cash (used in) provided by financing activities (42,397,000) 672,598,000 47,248,000
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 25,579,000 17,730,000 794,000
Net change in cash, cash equivalents, and restricted cash (5,100,000) 13,195,000 (6,927,000)
Cash, cash equivalents, and restricted cash, beginning of period 246,314,000 233,119,000 240,046,000
Cash, cash equivalents, and restricted cash, end of period 241,214,000 246,314,000 233,119,000
Supplemental cash flow information:      
Cash and cash equivalents 233,912,000 241,214,000 228,424,000
Restricted cash included in Other current assets 6,192,000 4,023,000 3,074,000
Restricted cash included in Other assets 1,110,000 1,077,000 1,621,000
Cash, cash equivalents, and restricted cash, end of period 241,214,000 246,314,000 233,119,000
Cash paid for income taxes 75,909,000 75,441,000 60,059,000
Cash paid for interest 100,754,000 70,775,000 72,461,000
Non-cash investing and financing activities:      
Purchases of Property, plant and equipment included in Accounts payable and Accrued liabilities 88,612,000 72,043,000 25,614,000
Assets acquired under finance leases $ 8,179,000 $ 1,567,000 $ 1,571,000